Endothelial progenitor cells display clonal restriction in multiple myeloma

dc.citation.epage12en_US
dc.citation.spage1en_US
dc.citation.volumeNumber6en_US
dc.contributor.authorBraunstein, M.en_US
dc.contributor.authorÖzçelik, T.en_US
dc.contributor.authorBaǧişlar, S.en_US
dc.contributor.authorVakil, V.en_US
dc.contributor.authorSmith, E. L. P.en_US
dc.contributor.authorDai, K.en_US
dc.contributor.authorAkyerli, C. B.en_US
dc.contributor.authorBatuman O. A.en_US
dc.date.accessioned2016-02-08T10:19:05Z
dc.date.available2016-02-08T10:19:05Z
dc.date.issued2006en_US
dc.departmentDepartment of Molecular Biology and Geneticsen_US
dc.description.abstractBackground: In multiple myeloma (MM), increased neoangiogenesis contributes to tumor growth and disease progression. Increased levels of endothelial progenitor cells (EPCs) contribute to neoangiogenesis in MM, and, importantly, covary with disease activity and response to treatment. In order to understand the mechanisms responsible for increased EPC levels and neoangiogenic function in MM, we investigated whether these cells were clonal by determining X-chromosome inactivation (XCI) patterns in female patients by a human androgen receptor assay (HUMARA). In addition, EPCs and bone marrow cells were studied for the presence of clonotypic immunoglobulin heavy-chain (IGH) gene rearrangement, which indicates clonality in B cells; thus, its presence in EPCs would indicate a close genetic link between tumor cells in MM and endothelial cells that provide tumor neovascularization. Methods: A total of twenty-three consecutive patients who had not received chemotherapy were studied. Screening in 18 patients found that 11 displayed allelic AR in peripheral blood mononuclear cells, and these patients were further studied for XCI patterns in EPCs and hair root cells by HUMARA. In 2 patients whose EPCs were clonal by HUMARA, and in an additional 5 new patients, EPCs were studied for IGH gene rearrangement using PCR with family-specific primers for IGH variable genes (VH). Results: In 11 patients, analysis of EPCs by HUMARA revealed significant skewing (≥ 77% expression of a single allele) in 64% (n = 7). In 4 of these patients, XCI skewing was extreme (≥ 90% expression of a single allele). In contrast, XCI in hair root cells was random. Furthermore, PCR amplification with VH primers resulted in amplification of the same product in EPCs and bone marrow cells in 71 % (n = 5) of 7 patients, while no IGH rearrangement was found in EPCs from healthy controls. In addition, in patients with XCI skewing in EPCs, advanced age was associated with poorer clinical status, unlike patients whose EPCs had random XCI. Conclusion: Our results suggest that EPCs in at least a substantial subpopulation of MM patients are related to the neoplastic clone and that this is an important mechanism for upregulation of tumor neovascularization in MM. © 2006 Braunstein et al; licensee BioMed Central Ltd.en_US
dc.description.provenanceMade available in DSpace on 2016-02-08T10:19:05Z (GMT). No. of bitstreams: 1 bilkent-research-paper.pdf: 70227 bytes, checksum: 26e812c6f5156f83f0e77b261a471b5a (MD5) Previous issue date: 2006en
dc.identifier.doi10.1186/1471-2407-6-161en_US
dc.identifier.issn1471-2407
dc.identifier.urihttp://hdl.handle.net/11693/23779
dc.language.isoEnglishen_US
dc.publisherBioMed Central Ltd.en_US
dc.relation.isversionofhttp://dx.doi.org/10.1186/1471-2407-6-161en_US
dc.source.titleBMC Canceren_US
dc.subjectAndrogen receptoren_US
dc.subjectImmunoglobulin heavy chainen_US
dc.subjectAdulten_US
dc.subjectAgeden_US
dc.subjectAgingen_US
dc.subjectAlleleen_US
dc.subjectArticleen_US
dc.subjectB lymphocyteen_US
dc.subjectBioassayen_US
dc.subjectClinical articleen_US
dc.subjectControlled studyen_US
dc.subjectEndothelium cellen_US
dc.subjectFemaleen_US
dc.subjectGene amplificationen_US
dc.subjectGene expressionen_US
dc.subjectGene rearrangementen_US
dc.subjectGenetic linkageen_US
dc.subjectHair rooten_US
dc.subjectHumanen_US
dc.subjectHuman cellen_US
dc.subjectMaleen_US
dc.subjectMolecular cloningen_US
dc.subjectMultiple myelomaen_US
dc.subjectNeovascularization (pathology)en_US
dc.subjectPeripheral blood mononuclear cellen_US
dc.subjectPolymerase chain reactionen_US
dc.subjectStem cellen_US
dc.subjectTumor cellen_US
dc.subjectTumor vascularizationen_US
dc.subjectUpregulationen_US
dc.subjectX chromosome inactivationen_US
dc.subjectAge Factorsen_US
dc.subjectClone Cellsen_US
dc.subjectEndothelial Cellsen_US
dc.subjectFemaleen_US
dc.subjectGene Rearrangementen_US
dc.subjectHumansen_US
dc.subjectImmunoglobulin Heavy Chainsen_US
dc.subjectMultiple Myelomaen_US
dc.subjectMultipotent Stem Cellsen_US
dc.subjectNeovascularization, Pathologicen_US
dc.subjectPrognosisen_US
dc.subjectReceptors, Androgenen_US
dc.subjectX Chromosome Inactivationen_US
dc.titleEndothelial progenitor cells display clonal restriction in multiple myelomaen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Endothelial progenitor cells display clonal restriction in multiple myeloma.pdf
Size:
1.94 MB
Format:
Adobe Portable Document Format
Description:
Full printable version